AVEO Pharmaceuticals (NASDAQ:AVEO) shares are skyrocketing in the pre-market session today after LG Chem agreed to acquire the company in an all-cash at $15 per share.
The move sets up a commercial presence for LG Chem’s Life Sciences division in the U.S. The transaction implies a fully diluted equity value of $566 million and is expected to close early next year.
AVEO shares have already almost doubled year-to-date.
Read full Disclosure
